141 related articles for article (PubMed ID: 7088380)
1. [Platelet aggregation in hyperlipoproteinemias].
Calabrese S; Da Col PG; Giansante C; Morgante O; Cattin L
Minerva Med; 1982 May; 73(22):1541-6. PubMed ID: 7088380
[TBL] [Abstract][Full Text] [Related]
2. Platelet function in hyperlipoproteinaemia.
Parízek M; Parízková M; Kubisz P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):752-9. PubMed ID: 2416652
[TBL] [Abstract][Full Text] [Related]
3. [Platelet aggregation and various coagulation parameters in liver cirrhosis].
Calabrese S; Giansante C; Sammartini C; Benedetti A
Minerva Med; 1984 Apr; 75(18):1047-52. PubMed ID: 6728255
[TBL] [Abstract][Full Text] [Related]
4. [Platelet factor 3 and 4 in juvenile diabetes and in children of diabetic mothers].
Calabrese S; Giansante C; Burigana F; Feruglio FS
Minerva Med; 1981 Sep; 72(34):2255-60. PubMed ID: 7290451
[TBL] [Abstract][Full Text] [Related]
5. In vivo platelet activity and lipoprotein patterns in coronary artery disease.
Goubran F; Maklady F; Saad M; el-Ashry M
Wien Klin Wochenschr; 1986 Apr; 98(7):209-11. PubMed ID: 3705598
[TBL] [Abstract][Full Text] [Related]
6. Platelet activity in vivo in hyperlipoproteinemia--importance of combined hyperlipidemia.
Bröijersén A; Hamsten A; Eriksson M; Angelin B; Hjemdahl P
Thromb Haemost; 1998 Feb; 79(2):268-75. PubMed ID: 9493574
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of platelet function and coagulation in deafness and sudden vestibular disorders].
Calabrese S; Giansante C; Oselladore F; Benedetti A; Mitri E
Minerva Med; 1983 May; 74(22-23):1357-63. PubMed ID: 6602306
[TBL] [Abstract][Full Text] [Related]
8. [Effect of halofenate on triglyceride and uric acid levels, coagulation and platelet behaviour in patients with hyperlipoproteinemia type IV and hyperuricemia (author's transl)].
Kuntzen O; Hehl FJ; Walter E; Zimmermann R
Arzneimittelforschung; 1978; 28(12):2349-52. PubMed ID: 227420
[TBL] [Abstract][Full Text] [Related]
9. Effect of pentoxifylline on platelet aggregation.
Nenci GG; Gresele P; Agnelli G; Ballatori E
Pharmatherapeutica; 1981; 2(8):532-8. PubMed ID: 7255510
[TBL] [Abstract][Full Text] [Related]
10. [Beta 2 glycoprotein I analysis in patients with hyperlipoproteinemia, arteriosclerotic occlusive disease and diabetes mellitus].
Müller G; Biering A; Lux E; Richter V
Z Gesamte Inn Med; 1983 May; 38(10):282-4. PubMed ID: 6613192
[TBL] [Abstract][Full Text] [Related]
11. [Effect of hyperlipoproteinemia on blood fibrinolytic activity and thrombocyte aggregation].
Kostić N; Secen S
Med Pregl; 2000; 53(3-4):180-3. PubMed ID: 10965685
[TBL] [Abstract][Full Text] [Related]
12. [Platelet aggregation in whole blood and prostacyclin in hyperlipemia types II and IV].
Craveri A; Lanfredini M; Citella C; Barbesti S; Tempesta A; Gallo E
Minerva Med; 1988 May; 79(5):349-54. PubMed ID: 3374826
[TBL] [Abstract][Full Text] [Related]
13. [Hyperlipoproteinemias in diabetes mellitus].
Slavina LS; Romanovskaia GA; Kantordzhan IG; Mazovetskiĭ AG; Riazanovskaia IV
Probl Endokrinol (Mosk); 1983; 29(3):17-21. PubMed ID: 6866949
[TBL] [Abstract][Full Text] [Related]
14. "Spontaneous" platelet aggregation in whole blood in diabetic and non diabetic survivors of acute myocardial infarction.
Gray RP; Hendra TJ; Patterson DL; Yudkin JS
Thromb Haemost; 1993 Dec; 70(6):932-6. PubMed ID: 8165614
[TBL] [Abstract][Full Text] [Related]
15. Platelet alpha 2-adrenergic receptors in hypercholesterolemia: relationship between binding studies and epinephrine-induced platelet aggregation.
Baldassarre D; Mores N; Colli S; Pazzucconi F; Sirtori CR; Tremoli E
Clin Pharmacol Ther; 1997 Jun; 61(6):684-91. PubMed ID: 9209252
[TBL] [Abstract][Full Text] [Related]
16. Behaviour of uricemia in hyperlipoproteinemic subjects.
Zdrenghea D; Marta D; Constantinescu M; Cucuianu M
Med Interne; 1980; 18(4):385-90. PubMed ID: 7455583
[TBL] [Abstract][Full Text] [Related]
17. Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus. The REGICOR Investigators.
Aubó C; Sentí M; Marrugat J; Tomás M; Vila J; Sala J; Masiá R
Eur Heart J; 2000 Jan; 21(1):33-8. PubMed ID: 10610741
[TBL] [Abstract][Full Text] [Related]
18. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis].
Jäger E; Sinzinger H; Widhalm K; Kaliman J; Höfer R
Wien Klin Wochenschr; 1982 Sep; 94(16):421-5. PubMed ID: 7147981
[TBL] [Abstract][Full Text] [Related]
19. [Effects of nitrates and beta-blockers on platelet aggregation in patients with coronary heart disease].
Wlazłowski R; Kruszyński G; Goch JH
Pol Merkur Lekarski; 2000 Feb; 8(44):77-9. PubMed ID: 10808734
[TBL] [Abstract][Full Text] [Related]
20. Increased plasma fibrinogen and platelet-aggregates in type II hyperlipoproteinaemia.
Lowe GD; Drummond MM; Third JL; Bremner WF; Forbes CD; Prentice CR; Lawrie TD
Thromb Haemost; 1980 Feb; 42(5):1503-7. PubMed ID: 7368154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
